Diphenidine: a dissociative NPS makes an entrance on the drug scene
Diphenidine is a potent synthetic dissociative anesthetic drug that has recently emerged in drug markets of Europe, Japan and America. The aim of this review is to summarize the current knowledge about this drug concerning its chemistry, synthesis, prevalence, pharmacology, toxicology and metabolism, as well as its legal status. Analytical methodologies developed for the determination of diphenidine in biological specimens and published diphenidine-related intoxications, fatal or not, are also presented.
All the reviewed information was gathered through a detailed search of PubMed and the World Wide Web using proper keywords.
Diphenidine is not approved for medical or veterinary use, but it is used illicitly around the world for recreational purposes or as a substitute of other controlled dissociative drugs. It is available through the Internet in powder form for oral administration, smoking or vaporization. Since its first appearance in the drug market in 2013, seizures have been reported worldwide and its abuse has already caused intoxications and deaths in Europe and Japan, thus leading to its scheduling in the United Kingdom and Canada during the second semester of 2016.
Diphenidine is a harmful dissociative drug that recently gained serious concern for public health. International and local authorities should take all the appropriate actions and measures to avoid the expansion of this new threat.
KeywordsDiphenidine Dissociatives NPS Pharmacology and toxicology Metabolism Legal status
Compliance with ethical standards
Conflict of interest
There are no financial or other relations that could lead to a conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 2.European Monitoring Center for Drugs and Drug Addiction (EMCDDA) (2017) EMCDDA–Europol 2016 annual report on the implementation of council decision 2005/387/JHA.http://www.emcdda.europa.eu/system/files/publications/4724/TDAN17001ENN_PDFWEB.pdf. Accessed 10 Feb 2018
- 5.Deluca P, Davey Z, Di Furia L, Farre M, Flesland LH, Mannonen H, Majava A, Peltoniemi T, Pasinetti P, Pezzolesi C, Scherbaum N, Siemann H, Skutle A, Torrens M, van der Kreeft P, Iversen E, Schifano F (2012) Identifying emerging trends in recreational drug use: outcomes from the Psychonaut Web Mapping Project. Prog Psychopharmacol Biol Psychiatry 39:221–226CrossRefGoogle Scholar
- 6.Christian E (1924) Reaction of organo-magnesium compounds on α-amino nitriles. Bull Soc Chim Belg 33:483Google Scholar
- 11.Domino EF, Miller SC (2009) The Pharmacology of dissociatives. In: Ries RK, Fiellin DA, Miller SC, Saitz R (eds) Addiction medicine. Lippincott Williams & Wilkins, A Wolters Kluwer Business, Philadelphia, pp 231–240Google Scholar
- 15.Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Watanabe K, Suzuki O (2015) Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol 33:45–53CrossRefGoogle Scholar
- 16.Uchiyama N, Shimokawa Y, Kawamura M, Kikura-Hanajiri R, Hakamatsuka T (2014) Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol 32:266–281CrossRefGoogle Scholar
- 20.Cayman Chemical (2014) Diphenidine (hydrochloride) safety data sheet. https://www.caymanchem.com/msdss/15518m.pdf. Accessed 23 Oct 2017
- 21.Drugs-forum (2013) Diphenidine (1,2-diphenylethylpiperidine) drug info. https://drugs-forum.com/threads/diphenidine-1-2-diphenylethylpiperidine-drug-info.210615/. Accessed 4 Nov 2017
- 23.Kusano M, Zaitsu K, Taki K, Hisatsune K, Nakajima J, Moriyasu T, Asano T, Hayashi Y, Tsuchihashi H, Ishii A (2018) Fatal intoxication by 5F-ADB and diphenidine: detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS. Drug Test Anal 10:284–293CrossRefPubMedGoogle Scholar
- 24.Legislation.gov.uk (2016) Psychoactive Substances Act 2016. http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted. Accessed 23 Oct 2017
- 25.Government of Canada (2016) Regulations amending the food and drug regulations (Parts G and J - lefetamine, AH-7921, MT-45 and W-18). http://www.gazette.gc.ca/rp-pr/p2/2016/2016-06-01/html/sor-dors106-eng.php. Accessed 23 Oct 2017
- 27.Pubchem Open Chemistry Database (2018) 1-(1,2-Diphenylethyl)piperidine. https://pubchem.ncbi.nlm.nih.gov/compound/206666. Accessed 25 Feb 2018
- 28.Wikipedia (2017) Diphenidine. https://en.wikipedia.org/wiki/Diphenidine. Accessed 23 Oct 2017
- 29.Psychonautwiki (2018) Diphenidine. https://psychonautwiki.org/wiki/Diphenidine. Accessed 23 Feb 2018
- 30.Wallach J, Kavanagh P, McLaughlin G, Morris N, Power J, Elliott S, Mercier M, Lodge D, Morris H, Dempster N, Brandt S (2015) Preparation and characterization of the ‘research chemical’ diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Drug Test Anal 7:358–367CrossRefPubMedGoogle Scholar
- 31.Maddox VH (1981) The historical development of phencyclidine. In: Domino EF (ed) PCP (phencyclidine): historical and current perspectives. NPP Books, Ann Arbor, pp 1–8Google Scholar
- 32.Cheng BK, Gray NM (1989) Preparation of 1,2-diarylethylamines for treatment of neurotoxic injury. EU patent no. EP346791A1Google Scholar
- 34.Geyer PM, Hulme MC, Irving JP, Thompson PD, Ashton RN, Lee RJ, Johnson L, Marron J, Banks CE, Sutcliffe OB (2016) Guilty by dissociation-development of gas chromatography-mass spectrometry (GC-MS) and other rapid screening methods for the analysis of 13 diphenidine-derived new psychoactive substances (NPSs). Anal Bioanal Chem 408:8467–8481CrossRefPubMedGoogle Scholar
- 39.Wallach J, Kang H, Colestock T, Morris H, Bortolotto ZA, Collingridge GL, Lodge D, Halberstadt AL, Brandt SD, Adejare A (2016) Pharmacological investigations of the dissociative ‘legal highs’ diphenidine, methoxphenidine and analogues. PLoS One 11:e0157021. https://doi.org/10.1371/journal.pone.0157021 CrossRefPubMedPubMedCentralGoogle Scholar
- 45.National Institute of Health Sciences (Tokyo) (2017) Data search system for new psychoactive substances. http://npsdb.nihs.go.jp/Search/. Accessed 23 Oct 2017